Evaluating the Impact of Smoking and Hyperlipidemia in Patients with Atherosclerotic Cardiovascular Disease

Smoking and Hyperlipidemia in Atherosclerosis

Authors

  • Hassan Raza Lahore Medical and Dental College, Lahore, Pakistan
  • Beya Idrees Lahore Medical and Dental College, Lahore, Pakistan
  • Hasaan Ullah Khan Lahore Medical and Dental College, Lahore, Pakistan
  • Kainat Bakhtiar Lahore Medical and Dental College, Lahore, Pakistan
  • . Ahmed Department of Physiology, Rai Medical College, Sargodha, Pakistan
  • Sobaan Ahmad Lahore Medical and Dental College, Lahore, Pakistan
  • Arslan Shuja Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v5i04.1441

Keywords:

Body Mass Index, Cholesterol, Triglycerides, Lipoproteins

Abstract

Hyperlipidemia and Smoking are risk factors of atherosclerotic cardiovascular disease in Pakistani community. Objectives: To determine whether smoking and hyperlipidemia were associated with atherosclerotic cardiovascular disease. Methods: A comparative, cross-sectional study was conducted upon a sample of 200 male and female participants with different cardiac complications were selected and divided them into different groups like Group A and Group B. The individuals with medical complications such as severe chest pain, unexpected numbness or weakness in arms or legs and loss of vision were placed in Group A. While in Group-B 70 male and 30 female individuals with mild chest pain were include. BMI, Cholesterol, Triglyceride, LDL and HDL levels and other demographics such as age, smoking habits were measured respectively. Results: In Group A (severe disease group) there were 75 males and 25 females while in Group B (mild disease group) 70 male and 30 female individuals were listed. The mean age in Group A (59.09 ± 0.01) and Group B (59.09 ± 0.01). The results showed significant difference in Group A and B mean cholesterol (279.9 ± 0.04 vs. 239.09 ± 0.04), Triglycerides (187.02 ± 0.01 vs. 127.02 ± 0.01), LDL (153.01 ± 0.02 vs. 123.01 ± 0.02), HDL (49.04 ± 0.01 vs. 40.01 ± 0.01) and (p value<0.05). Conclusions: It was concluded that hyperlipidemia and smoking were significant (p≤0.05) risk factors for atherosclerotic cardiovascular disease, as seen by increasing levels of cholesterol, Triglycerides and LDL in cardiovascular patients.

References

Guddeti RR, Patil S, Ahmed A, Sharma A, Aboeata A, Lavie CJ et al. Lipoprotein (a) and calcific aortic valve stenosis: A systematic review. Progress in Cardiovascular Diseases. 2020 Jul; 63(4): 496-502. doi: 10.1016/j.pcad.2020.06.002. DOI: https://doi.org/10.1016/j.pcad.2020.06.002

Qian XL, Cao H, Zhang J, Gu ZH, Tang WQ, Shen L et al. The prevalence, relative risk factors and MTHFR C677T genotype of H type hypertension of the elderly hypertensives in Shanghai, China: a cross-section study: prevalence of H type hypertension. BMC Cardiovascular Disorders. 2021 Dec; 21: 1-0. doi: 10.1186/s12872-021-02151-x. DOI: https://doi.org/10.1186/s12872-021-02151-x

El Rabbat KE, Mustafa SA, Farag SI, Helmy SM, Mahm DM. Correlation of epicardial adipose tissue and pericoronary fat thickness quantified by coronary computed tomography angiography with severity of coronary artery disease. Benha Journal of Applied Sciences. 2022 Feb; 7(2): 97-100. doi: 10.21608/bjas.2022.223935. DOI: https://doi.org/10.21608/bjas.2022.223935

Gałąska R, Kulawiak-Gałąska D, Dorniak K, Stróżyk A, Sabisz A, Chmara M et al. Aortic Wall Thickness as a Surrogate for Subclinical Atherosclerosis in Familial and Nonfamilial Hypercholesterolemia: Quantitative 3D Magnetic Resonance Imaging Study and Interrelations with Computed Tomography Calcium Scores, and Carotid Ultrasonography. Journal of Clinical Medicine. 2023 Aug; 12(17): 5589. doi: 10.3390/jcm12175589. DOI: https://doi.org/10.3390/jcm12175589

Zhang Y, Liu W, Zhang W, Cheng R, Tan A, Shen S et al. Association between blood lead levels and hyperlipidemiais: Results from the NHANES (1999–2018). Frontiers in Public Health. 2022 Sep; 10: 981749. doi: 10.3389/fpubh.2022.981749. DOI: https://doi.org/10.3389/fpubh.2022.981749

Witkowska AM, Waśkiewicz A, Zujko ME, Cicha-Mikołajczyk A, Mirończuk-Chodakowska I, Drygas W. Dietary plant sterols and phytosterol-enriched margarines and their relationship with cardiovascular disease among polish men and women: The WOBASZ II cross-sectional study. Nutrients. 2022 Jun; 14(13): 2665. doi: 10.3390/nu14132665. DOI: https://doi.org/10.3390/nu14132665

Huangfu G, Jaltotage B, Pang J, Lan NS, Abraham A, Otto J et al. Hepatic fat as a novel marker for high-risk coronary atherosclerotic plaque features in familial hypercholesterolaemia. Metabolism. 2023 Feb; 139: 155370. doi: 10.1016/j.metabol.2022.155370. DOI: https://doi.org/10.1016/j.metabol.2022.155370

Khoshbayan A, Taheri F, Moghadam MT, Chegini Z, Shariati A. The association of Chlamydia pneumoniae infection with atherosclerosis: Review and update of in vitro and animal studies. Microbial Pathogenesis. 2021 May; 154: 104803. doi: 10.1016/j.micpath.2021.104803. DOI: https://doi.org/10.1016/j.micpath.2021.104803

Memon SA, Adil M, Khan FR, Ullah S, Rehmat S, Gul NZ. Association between erectile dysfunction, cardiovascular risk factors, and coronary artery disease: Role of exercise stress testing and International Index of Erectile Function (IIEF-5) questionnaire. IJC Heart and Vasculature. 2022 Jun; 40: 101033. doi: 10.1016/j.ijcha.2022.101033. DOI: https://doi.org/10.1016/j.ijcha.2022.101033

Choi AD, Marques H, Kumar V, Griffin WF, Rahban H, Karlsberg RP et al. CT evaluation by artificial intelligence for atherosclerosis, stenosis and vascular morphology(CLARIFY): a multi-center, international study. Journal of Cardiovascular Computed Tomography. 2021 Nov; 15(6): 470-6. doi: 10.1016/j.jcct.2021.05.004. DOI: https://doi.org/10.1016/j.jcct.2021.05.004

Fu X, Xu J, Zhang R, Yu J. The association between environmental endocrine disruptors and cardiovascular diseases: a systematic review and meta-analysis. Environmental Research. 2020 Aug; 187: 109464. doi: 10.1016/j.envres.2020.109464. DOI: https://doi.org/10.1016/j.envres.2020.109464

Sutton NR, Banerjee S, Cooper MM, Arbab-Zadeh A, Kim J, Arain MA et al. Coronary artery disease evaluation and management considerations for high risk occupations: commercial vehicle drivers and pilots. Circulation: Cardiovascular Interventions. 2021 Jun; 14(6): e009950. doi: 10.1161/CIRCINTERVENTIONS.120.009950. DOI: https://doi.org/10.1161/CIRCINTERVENTIONS.120.009950

Lou IX, Chen J, Ali K, Chen Q. Relationship Between Hypertension, Antihypertensive Drugs and Sexual Dysfunction in Men and Women: A Literature Review. Vascular Health and Risk Management. 2023 Dec: 691-705. doi: 10.2147/VHRM.S439334. DOI: https://doi.org/10.2147/VHRM.S439334

Farooqui AA. Role of dyslipidemia in atherosclerosis. Stroke Revisited: Dyslipidemia in Stroke. 2021: 3-14. doi: 10.1007/978-981-16-3923-4_1. DOI: https://doi.org/10.1007/978-981-16-3923-4_1

Marchio P, Guerra-Ojeda S, Vila JM, Aldasoro M, Victor VM, Mauricio MD. Targeting early atherosclerosis: a focus on oxidative stress and inflammation. Oxidative Medicine and Cellular Longevity. 2019 Oct; 2019. doi: 10.1155/2019/8563845. DOI: https://doi.org/10.1155/2019/8563845

Carpenter M, Sinclair H, Kunadian V. Carotid intima media thickness and its utility as a predictor of cardiovascular disease: a review of evidence. Cardiology in Review. 2016 Mar; 24(2): 70-5. doi: 10.1097/CRD.0000000000000077. DOI: https://doi.org/10.1097/CRD.0000000000000077

Ray KK, Molemans B, Schoonen WM, Giovas P, Bray S, Kiru G et al. EU-Wi de Cross-Section al Obser v at ion al Study of Lipid-Modifying Therapy Use in Se c ondary and Pr i mary Care: the DA VINCI study. European journal of preventive cardiology. 2021 Nov 1;28(11):1279-89. doi: 10.1093/eurjpc/zwaa047. DOI: https://doi.org/10.1093/eurjpc/zwaa047

Aschauer J, Aschauer S, Pollreisz A, Datlinger F, Gatterer C, Mylonas G et al. Identification of subclinical microvascular biomarkers in coronary heart disease in retinal imaging. Translational Vision Science and Technology. 2021 Nov; 10(13): 24-. doi: 10.1167/tvst.10.13.24. DOI: https://doi.org/10.1167/tvst.10.13.24

Hitl M, Gavarić N, Kladar N, Radovanović K, Srđenović B, Božin B. Phytotherapy in patients with cardiovascular diseases-A descriptive survey in Vojvodina, Serbia. Journal of Herbal Medicine. 2023 Sep; 41: 100684. doi: 10.1016/j.hermed.2023.100684. DOI: https://doi.org/10.1016/j.hermed.2023.100684

Strecker C, Krafft AJ, Kaufhold L, Hüllebrandt M, Weber S, Ludwig U et al. Carotid geometry is an independent predictor of wall thickness–a 3D cardiovascular magnetic resonance study in patients with high cardiovascular risk. Journal of Cardiovascular Magnetic Resonance. 2020 Dec; 22: 1-2. doi: 10.1186/s12968-020-00657-5. DOI: https://doi.org/10.1186/s12968-020-00657-5

Prem Senthil M, Kurban C, Thuy Nguyen N, Nguyen AP, Chakraborty R, Delaney C et al. Role of noninvasive ocular imaging as a biomarker in peripheral artery disease (PAD): A systematic review. Vascular Medicine. 2024 Apr; 29(2): 215-22. doi: 10.1177/1358863X231210866. DOI: https://doi.org/10.1177/1358863X231210866

Cardoso R, Choi AD, Shiyovich A, Besser SA, Min JK, Earls J et al. How early can atherosclerosis be detected by coronary CT angiography? Insights from quantitative CT analysis of serial scans in the PARADIGM trial. Journal of Cardiovascular Computed Tomography. 2023 Nov; 17(6): 407-12. doi: 10.1016/j.jcct.2023.08.012. DOI: https://doi.org/10.1016/j.jcct.2023.08.012

O’Riordan C, Savage E, Newell M, Flaherty G, Hartigan MSc I. Cardiovascular disease risk factor profile of experienced male amateur marathon runners: a systematic review. Sports Health. 2023 Sep; 15(5): 661-72. doi: 10.1177/19417381231176534. DOI: https://doi.org/10.1177/19417381231176534

Song XH, Liu B, Lei F, Liu YM, Zhang X, Chen Z et al. The Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Peripheral Arterial Disease in the Chinese Population. Diabetes, Metabolic Syndrome and Obesity. 2023 Dec: 373-84. doi: 10.2147/DMSO.S394414. DOI: https://doi.org/10.2147/DMSO.S394414

Di Minno MN, Gentile M, Di Minno A, Iannuzzo G, Calcaterra I, Buonaiuto A et al. Changes in carotid stiffness in patients with familial hypercholesterolemia treated with Evolocumab®: A prospective cohort study. Nutrition, Metabolism and Cardiovascular Diseases. 2020 Jun; 30(6): 996-1004. doi: 10.1016/j.numecd.2020.02.018. DOI: https://doi.org/10.1016/j.numecd.2020.02.018

de Isla LP, Alonso R, de Diego JJ, Muñiz-Grijalvo O, Díaz-Díaz JL, Zambón D et al. Coronary plaque burden, plaque characterization and their prognostic implications in familial hypercholesterolemia: A computed tomographic angiography study. Atherosclerosis. 2021 Jan; 317: 52-8. doi: 10.1016/j.atherosclerosis.2020.11.012. DOI: https://doi.org/10.1016/j.atherosclerosis.2020.11.012

Jonas RA, Weerakoon S, Fisher R, Griffin WF, Kumar V, Rahban H et al. Interobserver variability among expert readers quantifying plaque volume and plaque characteristics on coronary CT angiography: a CLARIFY trial sub-study. Clinical Imaging. 2022 Nov; 91: 19-25. doi: 10.1016/j.clinimag.2022.08.005. DOI: https://doi.org/10.1016/j.clinimag.2022.08.005

Lee ZV, Llanes EJ, Sukmawan R, Thongtang N, Ho HQ, Barter P, Cardiovascular RISk Prevention (CRISP) in Asia Network. Prevalence of plasma lipid disorders with an emphasis on LDL cholesterol in selected countries in the Asia-Pacific region. Lipids in Health and Disease. 2021 Dec; 20: 1-2. doi: 10.1186/s12944-021-01450-8. DOI: https://doi.org/10.1186/s12944-021-01450-8

Downloads

Published

2024-04-30
CITATION
DOI: 10.54393/pjhs.v5i04.1441
Published: 2024-04-30

How to Cite

Raza, H., Idrees, B., Khan, H. U., Bakhtiar, K., Ahmed, ., Ahmad, S., & Shuja, A. (2024). Evaluating the Impact of Smoking and Hyperlipidemia in Patients with Atherosclerotic Cardiovascular Disease : Smoking and Hyperlipidemia in Atherosclerosis. Pakistan Journal of Health Sciences, 5(04), 136–140. https://doi.org/10.54393/pjhs.v5i04.1441

Issue

Section

Original Article

Plaudit